Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases

Clinical trial NCT07544225 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07544225
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Sjogren's Disease With Dry Eyes Systemic Sclerosis (SSc)Idiopathic Inflammatory Myositis (IIM)

Start date: 2026-09-01
Primary completion: 2029-02-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.